Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. (Q51984235)
Jump to navigation
Jump to search
scientific article published in May 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. |
scientific article published in May 1999 |
Statements
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. (English)
1 reference
Revicki DA
1 reference
Moyle G
1 reference
Stellbrink HJ
1 reference
Barker C
1 reference
1 May 1999
1 reference
1 reference
13
1 reference
7
1 reference
851-858
1 reference